Form 4 for CRL Charles River Laboratories
Accepted 2023-11-13 00:00:00 ET · period of report 2023-11-09 · accession 0001127602-23-027226 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-13 | 2023-11-09 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $173.48 | -9,128 | 25.0K | -27% | -$1.58M |
| D | 2023-11-13 | 2023-11-09 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $144.67 | +9,128 | 34.1K | +37% | +$1.32M |
| D | 2023-11-13 | 2023-11-09 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $0.00 | -9,128 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-09 | S | D | 2,585 | $172.77 | 31,526 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $172.32 to $173.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-11-09 | M | A | 9,128 | $144.67 | 34,111 | D | — | — | |
| 3 | Common | Common Stock | 2023-11-09 | S | D | 6,543 | $173.76 | 24,983 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $173.74 to $174.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Stock Options (Right to Buy) | 2023-11-09 | M | D | 9,128 | $0.00 | 0 | D | $144.67 · 2020-02-22 to 2024-02-22 | 9,128 Common Stock |